![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 20, 18077-18083, May 17, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of
Received for publication, October 22, 2001, and in revised form, February 26, 2002
Exposure to ultraviolet light can cause
inflammation, premature skin aging, and cancer. UV irradiation
alters the expression of multiple genes that encode functions to repair
DNA damage, arrest cell growth, and induce apoptosis. In addition, UV
irradiation inhibits protein synthesis, although the mechanism is not
known. In this report, we show that UV irradiation induces
phosphorylation of eukaryotic translation initiation factor 2 on the
UV irradiation causes the increased or reduced expression of
multiple genes that encode functions to repair DNA damage (1), arrest
cell growth (2, 3), and induce apoptosis (4). The transcriptional
regulation upon UV irradiation has been extensively studied (5, 6).
However, translational regulation upon UV irradiation has not been well
investigated. In this study we elucidate a novel UV-activated signaling
pathway that emanates from the endoplasmic reticulum
(ER)1 and inhibits protein
synthesis by phosphorylation of the Accumulation of unfolded proteins in the ER induces eIF2 It was reported that UV irradiation inhibits protein synthesis in rat
fibroblasts (16). However, the mechanism for UV-induced protein
synthesis inhibition is not clear. It was proposed that UV-induced
translational inhibition undergoes a ribotoxic stress signaling
pathway, which is based on the fact that the UV-induced translational
inhibition is correlated with rRNA damage and JNK activation (16). In
this article we provide evidence that UV irradiation induces
phosphorylation of eIF2 Construction of Mammalian Expression Vectors for PERK, Mutant
PERK (K618A), the Luminal Domain of PERK (PERK
To construct the pBiP-EGFP vector the BiP promoter was
excised from pGL3-BiP using restriction enzyme digestion and was
subcloned into pd2EGFP-1 (Stratagene, La Jolla, CA), which encodes a
short-lived form of EGFP.
Cell Culture and Derivation of the PERK
For construction of an MCF-7 cell line that expresses PERK Detection of BiP Promoter Activation--
MCF-7 cells were
plated in a 6-well plate at a density of 5 × 105
cells per well at 18 h pretransfection. The cells were transfected with pd2EGFP-BiP (0.8 µg/well) using LipofectAMINE Plus (Invitrogen) according to the manufacturer's protocol. At 18 h
post-transfection, the cells were irradiated with 30 J/m2
UVC. The images of EGFP expression were then captured by an Olympus IX70 fluorescence microscope (Olympus America Inc., Melville, NY) using
a Kodak M290 camera (Eastman Kodak Co.) with an exposure time of
0.25 s.
The expression of GFP was quantified by Image* Pro Plus 4.1 (Media
Cybernetics, Inc., Silver Spring, MD) for each cell count integrated
optical density of the green channel. Merged cells were manually
separated, and artifacts (items or noise too small to be cells) were
removed before the quantitation. The average integrated optical density
per cell was generated by Microsoft Excel (Microsoft Co., Seattle, WA).
UV Irradiation--
UVC was generated from a 15-watt UVC light
source (UVP Inc., Upland, CA). The intensity of UVC was standardized
using a UV meter (UVP Inc.) and set at 3 watts/m2. The
medium was withdrawn during the UVC irradiation. After UV irradiation fresh medium was added to each plate.
Analysis of Protein Synthesis--
The UV-irradiated cells were
labeled with Redivue Pro Mix [35S]Met/Cys (100 µCi/ml;
1,000 Ci/mmol; Amersham Biosciences) for 20 min in
methionine/cysteine-free minimal essential medium (Invitrogen). After
washing with phosphate-buffered saline cell extracts were prepared by
lysing the cells in Nonidet P-40 lysis buffer (2% Nonidet P-40, 80 mM NaCl, 100 mM Tris-HCl, 0.1% SDS). The
protein concentration was measured using the Bio-Rad protein DC assay kit. The 35S incorporation was measured by trichloroacetic
acid precipitation and analyzed by SDS-PAGE.
For electrophoresis equal amounts of protein from cell lysates were
resolved on a 12% SDS-PAGE. The gel was stained with Coomassie Blue
(R-250), prepared for fluorography by treatment with En3Hance (PerkinElmer Life Sciences), dried, and autoradiographed.
For trichloroacetic acid precipitation equal amounts of cell lysate
were added to 0.5 ml of 0.1 mg/ml bovine serum albumin containing
0.02% sodium azide and placed on ice. Ice-cold 20% trichloroacetic
acid (0.5 ml) was added, vortexed vigorously, and incubated for 30 min
on ice. The cell suspension was filtered through a Millipore filtration
apparatus onto a glass microfiber disc (Whatman). Disks were washed
twice with 1 ml of ice-cold 10% trichloroacetic acid and twice with 1 ml of 100% ethanol. Disks were air-dried, and the radioactivity was
measured in a scintillation counter (Packard Instrument Co.).
Assay for eIF2 Dimerization Analysis of Intact PERK and the Luminal Domain of
PERK--
COS-1 cells were transiently transfected with
pETFVA UV Irradiation Inhibits Protein Synthesis in a Dosage- and
Time-dependent Manner--
To first establish that UV
irradiation inhibits protein synthesis, a 35S incorporation
assay was used to quantify the rate of protein synthesis after
irradiation. MCF-7 cells were irradiated with increasing doses of UVC
and metabolically labeled with [35S]Met/Cys at 4 h
post-irradiation. Analysis by SDS-PAGE and trichloroacetic acid
precipitation demonstrated that protein synthesis was reduced to 56%
with increasing doses of irradiation (Fig.
1A, left panel). At
30 J/m2 protein synthesis was reduced to 18% 24 h
after UV irradiation (Fig. 1B, left panel).
However, translational recovery was observed at 48 h
postirradiation (Fig. 1B, left panel). Because
the same quantity of protein was loaded in each lane (Fig. 1,
A and B, right panels) the amount of
35S incorporation represents the relative level of protein
translation. Previously published studies demonstrated that protein
synthesis could be inhibited within 10 min in fibroblasts after a high
dose (300-600 J/m2) of UVC irradiation (16). Our results
indicate that translational inhibition can occur at a much lower dose
(30 J/m2) of UV irradiation and is dosage- and
time-dependent. In addition protein synthesis is eventually
restored after UV irradiation (Fig. 1B). Therefore,
UV-induced protein synthesis inhibition is a prolonged and reversible
process.
UV Irradiation Induces eIF2 UV Irradiation Induces eIF2 PERK Mediates UV-induced eIF2 UV Irradiation Activates BiP Promoter--
It was reported that UV
irradiation induces the activation of CHOP10 (24), an
ER-stress-inducible gene (25). ER-stress-induced CHOP10
activation may be mediated by ATF4, which is downstream of PERK
activation and eIF2 Expression of a Dominant-negative PERK (PERK PERK
In summary, our findings demonstrate that UV irradiation induces an
ER-stress-induced signaling pathway that activates PERK and inhibits
protein synthesis in mammalian cells. These studies are a first step to
understand the mechanistic details of how UV light activates an
ER-stress response that may mediate downstream responses. We
hypothesize that UV light disrupts protein folding in the ER resulting
in the accumulation of unfolded proteins to promote PERK dimerization
and activation. PERK-mediated phosphorylation of eIF2 We thank Jeffrey C. Hanson of the Scientific
Imaging Center, Eli Lilly and Company, for help with the GFP quantification.
*
This work was supported in part by National Institutes of
Health Grants RO1 CA86926 (to S. W.) and RO1 AI42394 (to R. J. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Rm. 4131, 1331 E. Ann
St., Ann Arbor, MI 48109-0581. Tel.: 734-647-6679; Fax: 734-763-1581;
E-mail: shiyongw@umich.edu.
Published, JBC Papers in Press, March 4, 2002, DOI 10.1074/jbc.M110164200
2
D. Ron, personal communication.
The abbreviations used are:
ER, endoplasmic
reticulum;
UVC, ultraviolet light at 254 nm;
PKR, double-stranded
RNA-activated protein kinase;
PERK, PKR-like ER kinase;
PERK
Ultraviolet Light Inhibits Translation through Activation of the
Unfolded Protein Response Kinase PERK in the Lumen of the Endoplasmic
Reticulum*
§,
,
,
,
Radiation Oncology and
Biological Chemistry, The Howard Hughes Medical Institute,
University of Michigan Medical Center, Ann Arbor, Michigan 48109 and
the ¶ Endocrine Division, Lilly Research Laboratories, Eli Lilly
and Company, Indianapolis, Indiana 46285
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSIONS
REFERENCES
-subunit (eIF2
) and inhibits protein synthesis in a dosage- and
time-dependent manner. The UV-induced phosphorylation of
eIF2
was prevented by the overexpression of a non-phosphorylatable
mutant of eIF2
(S51A). PERK is an eIF2
protein kinase localized
to the endoplasmic reticulum that is activated by the accumulation of
unfolded proteins in the endoplasmic reticulum. Expression of
trans-dominant-negative mutants of PERK also prevented
eIF2
phosphorylation upon UV treatment and protected from the
associated translation attenuation. The luminal domain of
dominant-negative mutant PERK formed heterodimers with endogenous PERK
to inhibit the PERK signaling pathway. In contrast, eIF2
phosphorylation was not inhibited by overexpression of a
trans-dominant-negative mutant kinase, PKR, supporting the theory that UV-induced eIF2
phosphorylation is specifically mediated by PERK. These results support a novel mechanism by which UV
irradiation regulates translation via an endoplasmic
reticulum-stress signaling pathway.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSIONS
REFERENCES
-subunit of the eukaryotic
translation initiation factor 2 (eIF2
).
phosphorylation through activation of the eIF2
kinase, PERK (7-10). PERK contains a signal peptide (amino acids 1-31) and a domain (amino
acids 32-521) that resides in the ER lumen and shares 20% identity
with the ER-stress-sensing luminal domain of mammalian IRE1 (an
ER resident transmembrane kinase). The Ser/Thr protein kinase domain
(amino acids 589-1114) is 40% identical to the kinase domain of the
double-stranded RNA-activated eIF2
protein kinase PKR. PERK
specifically phosphorylates the serine 51 residue of eIF2
in
vitro and in vivo and thereby inhibits translation
initiation. Phosphorylation of eIF2
limits the frequency of
polypeptide chain initiation in general, although it can permit the
preferential translation of certain mRNAs, possibly those that have
open reading frames within the 5'-untranslated regions or those that
have internal ribosomal entry sites (11-14). One mRNA selectively
translated under these conditions encodes the basic leucine
zipper-containing activating transcription factor ATF4 that likely
contributes to ER-stress-induced transcription as a component of the
unfolded protein response. Expression of a catalytically inactive
PERK kinase mutant (K618A) acts in a trans-dominant-negative
manner to protect eIF2
from phosphorylation (8). Overexpression of PERK results in spontaneous activation to inhibit translation of its
own mRNA (8). Overexpression of the isolated luminal domain of PERK
(PERK
C) inhibits ER-stress-induced expression of a subset of
unfolded protein-responsive genes such as BiP and CHOP10 (GADD153) (8, 15).
and inhibits protein synthesis in intact
cells. We also provide evidence that the UV-induced eIF2
phosphorylation and translational inhibition are mediated by PERK
through an ER-stress signaling pathway.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSIONS
REFERENCES
C), and EGFP--
The
myc-tagged PERK and PERK (K618A) expression vectors (in
pcDNA1, Invitrogen, San Diego, CA) were kindly provided by Dr. David Ron (New York University School of Medicine). Using restriction enzyme digestion and ligation we subcloned the genes into the mammalian
expression vector pETFVA
, which is identical to the other
expression vectors (PKR mutants, eIF2
, and eIF2
-51A) used in our
experiments. The luminal domain of PERK (PERK
C, amino acids 1-536)
was amplified from pcDNA1-PERK using the PCR method. A high
fidelity DNA polymerase (Pwo, Roche Molecular Biochemicals) was used
for the PCR. A T7 tag (MASMTGGQQMG) was added to the C terminus
of PERK
C. The PCR products were subcloned into the mammalian
expression vector pETFVA
.
C Stably Transfected
MCF-7 Cell Line--
COS-1 cells were cultured in Dulbecco's modified
Eagle's medium containing 10% fetal calf serum and
penicillin/streptomycin (100 units/ml). MCF-7 and hamster insulinoma
tumor (HIT) cells were cultured in RPMI 1640 medium containing 10%
fetal calf serum and penicillin/streptomycin (100 units/ml). All of the
above reagents were purchased from Invitrogen.
C the
PERK
C was subcloned from pETFVA
-PERK
C into the pZ
vector to form pZ-PERK
C. MCF-7 cells were transfected with
pZ-PERK
C using LipofectAMINE Plus reagent (Invitrogen) and selected
with G418 (0.5 mg/ml, Invitrogen). Expression of PERK
C was detected
by Western blot analysis using anti-PERK antibody. The PERK
C stably
transfected MCF-7-PERK
C cells were identified and cultured in
medium containing 0.5 mg/ml G418.
Phosphorylation--
For analysis of
endogenous eIF2
phosphorylation HIT cells were irradiated with 50 J/m2 UVC. Immediately after UV irradiation, the cells were
cultured in fresh medium containing 0.5 µM okadaic
acid (OA) and 100 µM N-acetyl-L-leucinyl-norleucinal (ALLN). At
4 h postirradiation the cells were lysed in Nonidet P-40 lysis
buffer, and protein concentration was determined using the Bio-Rad
protein assay kit. Equal amounts of proteins were resolved by SDS-PAGE
and electroblotted to nitrocellulose membrane. The total amount of
eIF2
and phosphorylated eIF2
were probed with antibodies against
eIF2
and phosphorylated eIF2
(Research Genetics, Inc.,
Huntsville, AL) (17). The levels of eIF2
expression and
phosphorylation were visualized by the SuperSignal chemiluminescent
system as recommended by the supplier (Pierce). For phosphorylation
analysis of the transiently transfected eIF2
, COS-1 cells were
transiently transfected with eIF2
expression vector
(pETFVA
-2
) by the DEAE-dextran procedure as described
previously (18). After 48 h the transfected cells were
UV-irradiated and lysed in the Nonidet P-40 lysis buffer containing
proteinase inhibitor mixture (CompleteTM, Roche Molecular
Biochemicals) at the indicated postirradiation time. The expression
levels of eIF2
in each sample were first determined by Western blot
analysis using a mouse anti-eIF2
monoclonal antibody (19). After
quantification of the expression levels of eIF2
equal amounts of
eIF2
were subjected to SDS-PAGE followed by Western blot analysis.
The levels of eIF2
expression and phosphorylation were determined
using the same methods as described above.
-PERK (K618A)-myc and
pETFVA
-PERK
C-T7 using the DEAE-dextran procedure.
After 48 h the cells were pulse-labeled using
[35S]Met/Cys for 20 min in Met/Cys-free minimal essential
medium. Cell extracts were prepared by lysis in the Nonidet P-40 lysis buffer. The dimerization of PERK (K618A)-myc and PERK
C-T7
was detected by co-immunoprecipitation using anti-T7 antibody or
anti-myc antibody in radioimmune precipitation buffer.
Antibody-antigen complexes were absorbed by protein A/G-agarose
(Pierce) and resolved by 10% SDS-PAGE. The gels were fixed in 40%
methanol, 10% acetic acid, prepared for fluorography by treatment with
En3Hance (PerkinElmer Life Sciences), and dried. The dried gels were
autoradiographed with Kodak BioMax-MR film.
![]()
RESULTS AND DISCUSSIONS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSIONS
REFERENCES

View larger version (52K):
[in a new window]
Fig. 1.
UV inhibits nascent protein synthesis in a
dosage- and time-dependent manner. Total cell extracts
(30 µg) from UV-irradiated and [35S]Met/Cys
pulse-labeled MCF-7 cells were resolved by 12% SDS-PAGE, stained with
Coomassie Blue R-250 (right panel), treated with En3Hance
(PerkinElmer Life Sciences), and dried. The nascent protein synthesis
was determined by autoradiography (left panel).
A, dose-dependent inhibition of translation at
4 h post-UV; B, time-dependent inhibition
of translation after 30 J/m2 UVC.
Phosphorylation in HIT
Cells--
To further elucidate the mechanism of UV-induced
translational inhibition we examined whether UV irradiation induces the
phosphorylation of endogenous eIF2
. Because endogenous eIF2
is
not detectable in MCF-7 cells we used hamster insulinoma tumor (HIT)
cells, which express a higher level of eIF2
. The cells were
irradiated with 50 J/m2 UVC. To prevent the
dephosphorylation and degradation of the phosphorylated proteins cells
were cultured in medium containing OA and ALLN for 4 h
after irradiation and lysed in Nonidet P-40 lysis buffer. The
phosphorylation state of eIF2
was then examined. Phosphorylation of
eIF2
increased when cells were treated with OA and ALLN alone (Fig.
2A) and was likely caused by
the inhibition of phosphatase-1 and phosphatase-2A by OA as previously
reported (20). When the cells were treated with UV the phosphorylation of eIF2
increased further by 70% (Fig. 2A). These
results show that UV irradiation induces endogenous eIF2
phosphorylation. PERK activation was also examined in these cells.
However, we were unable to detect a significant increase in PERK
phosphorylation in the UV-irradiated cells (data not shown).
This may be because UV-induced PERK activation is a prolonged
process that does not produce a clear up-shifting band as is normally
observed for phosphorylated PERK
(21).2

View larger version (23K):
[in a new window]
Fig. 2.
UV induces endogenous eIF2
phosphorylation. Total cell extracts prepared from
UV-irradiated HIT cells or eIF2
transfected COS-1 cells were
resolved by 12% SDS-PAGE and electroblotted to nitrocellulose
membranes. The amount of total eIF2
and phosphorylated eIF2
were
measured by Western blot analysis. The levels of eIF2
and
phosphorylated eIF2
were determined using NIH Image (Version 1.62f).
A, endogenous eIF2
phosphorylation in HIT cells;
B, dose-dependent phosphorylation of eIF2
at
4 h post-irradiation; C, time-dependent
phosphorylation of eIF2
after 50 J/m2 UV
irradiation.
Phosphorylation in a Dosage- and
Time-dependent Manner--
To further confirm that UV
irradiation induces eIF2
phosphorylation we analyzed whether
UV-induced eIF2
phosphorylation is dependent on dosage and time.
COS-1 cells were used in this experiment because the cell line is
conveniently and efficiently transiently transfected and expresses high
levels of proteins from transfected genes. In addition, because the
endogenous eIF2
is undetectable in COS-1 cells by Western blot
analysis (18, 19) the eIF2
that was detected represents eIF2
derived from transfected DNA in the subpopulation of transfected cells.
A mammalian expression vector encoding eIF2
was transiently
transfected into COS-1 cells, and phosphorylation of the expressed
eIF2
was detected using an antibody specific for the phosphorylated
form of eIF2
and compared with reactivity for an antibody that is
specific for total eIF2
(17). Because the levels of total
expressed eIF2
did not significantly vary at these doses and time
points (Fig. 2, B and C), differential reactivity
to the antibody specific for the phosphorylated form of eIF2
is
indicative of differential phosphorylation. The results demonstrate
that a significant increase in eIF2
phosphorylation occurs within
4 h after irradiation at 50 and 100 J/m2 (Fig.
2B). At 50 J/m2 UV irradiation eIF2
phosphorylation was detectable after 2 h and peaked at 12 h.
The kinetics of eIF2
phosphorylation correlated with the inhibition
of protein synthesis after UV irradiation (Fig. 1B). In
addition these data are consistent with the restoration of protein
synthesis after 48 h of UV irradiation (Fig. 1B). Our results show that eIF2
phosphorylation in response to UV irradiation is dosage- and time-dependent (Fig. 2, B and
C). However, a high dosage (50-100 J/m2) of UV
was needed to visualize the eIF2
phosphorylation. Because a small
increase (10%) in the amount of phosphorylated eIF2
is sufficient
to inhibit protein synthesis initiation (22) lower doses of irradiation
(such as 30 J/m2) may also inhibit protein synthesis
through eIF2
phosphorylation although it is difficult to measure the
increase in eIF2
phosphorylation at these doses.
Phosphorylation--
Both PKR and
PERK were suggested to mediate stress-induced eIF2
phosphorylation
(8, 23). Overexpression of a dominant-negative kinase mutant PKR
(K296P) inhibits eIF2
phosphorylation catalyzed by endogenous PKR
(19). In addition, a kinase-defective K618A mutant PERK acts in a
trans-dominant-negative manner to inhibit eIF2
phosphorylation upon activation of endogenous PERK by ER-stress (8).
Overexpression of the isolated luminal domain of PERK (PERK
C)
inhibits ER-stress-induced transcriptional induction of
CHOP10, a gene that acts as a marker of the unfolded protein response (8, 15). We examined whether overexpression of the dominant-negative mutant forms of PKR and/or PERK could also inhibit UV-induced phosphorylation of eIF2
. COS-1 cells were transiently co-transfected with eIF2
and the expression vectors indicated (Fig.
3). The transfected cells were irradiated
with UVC. At 4 h post-irradiation the cells were harvested, and
the expression and phosphorylation of eIF2
were detected by Western
blot analysis using anti-eIF2
and anti-eIF2
-P antibodies as
described under "Materials and Methods." This analysis demonstrated
that the phosphorylation of overexpressed wild-type eIF2
increased
with UV treatment. However, overexpression of a phosphorylation site
mutant S51A eIF2
significantly prevented the phosphorylation of
co-transfected eIF2
upon UV treatment (Fig. 3, lanes
4-6). These results support the theory that phosphorylation of
eIF2
upon UV treatment occurs on residue Ser-51. Overexpression of
wild-type PERK constitutively increased eIF2
phosphorylation, which
was further increased after UV treatment (Fig. 3, lanes
10-12). Significantly, overexpression of either PERK (K618A) or
PERK
C inhibited UV-induced eIF2
phosphorylation (Fig. 3,
lanes 13-18). Although a previous report suggested that UV
irradiation (27 J/m2, 45 min) does not induce
autophosphorylation and activation of PERK (8) this analysis did not
vary the time and dosage of UV treatment. We believe that the
discrepancy is because of the time- and dosage-dependent
activation of PERK. Our data show that increased eIF2
phosphorylation cannot be detected at 4 h after 30 J/m2 irradiation (Fig. 2B). In contrast to
mutant PERK overexpression of the dominant-negative mutant PKR (K296P)
did not affect the UV-induced eIF2
phosphorylation (Fig. 3,
lanes 7-9). These results support that UV-induced eIF2
phosphorylation is specifically mediated by PERK and not by PKR.

View larger version (53K):
[in a new window]
Fig. 3.
Dominant-negative mutant PERK inhibits
UV-induced eIF2
phosphorylation. COS-1
cells were co-transfected with 0.5 µg of the eIF2
expression
vector and 2 µg of pETFVA
,
pETFVA
-eIF2
(S51A), pETFVA
-PKR (K296P),
pETFVA
-PERK, pETFVA
-PERK (K618A), or
pETFVA
-PERK
C. Total cell extracts from transfected and
UV-irradiated COS-1 cells were resolved by 12% SDS-PAGE and
electroblotted to nitrocellulose membranes. Western blot analysis was
used to determine the amount of total eIF2
and phosphorylated
eIF2
.
phosphorylation (26). However, it is not known
whether UV irradiation induces ER-stress to activate PERK. Because
increasing levels of the ER luminal chaperone BiP inhibit PERK
activation and eIF2
phosphorylation (21), we determined whether UV
irradiation activates the BiP promoter. A
BiP-regulated EGFP expression vector (pBiP-EGFP) was used as
a reporter to measure BiP promoter activation after UV
irradiation. UV irradiation induced GFP expression by 2.9-fold (15 J/m2 UV) to 3.8-fold (30 J/m2 UV) (Fig.
4B). In parallel, thapsigargin
(200 nM) induced GFP expression by 3.4-fold (Fig.
4B). Our data indicate that UV induction of the
BiP promoter is comparable with thapsigargin induction in
MCF-7 cells (Fig. 4, A and B). Therefore, UV
irradiation induces the ER-stress response, which results in the
activation of the BiP promoter. These results suggest that
UV-induced PERK activation with subsequent transcriptional induction of
BiP would increase the level of BiP in the ER lumen and
thereby prevent further PERK activation. Although UV treatment inhibits
protein synthesis it is possible that the BiP mRNA is
efficiently translated upon UV treatment because it has an internal
ribosomal entry site element within the 5' end of its mRNA. Indeed,
recent studies demonstrated that internal ribosomal entry site-mediated
translation is not inhibited upon eIF2
phosphorylation (13,
14).

View larger version (32K):
[in a new window]
Fig. 4.
UV activates the BiP
promoter. The pBiP-EGFP (1.3 µg/ml) transfected MCF-7
cells were either left untreated or treated with 15 J/m2 UVC, 30 J/m2 UVC, or 200 nM
thapsigargin (Tg) as indicated at 18 h
post-transfection. A, EGFP fluorescence emitted at 505 nm
was captured at 0 and 6 h postirradiation; B,
expression of EGFP was determined by Image* Pro Plus 4.1 (Media
Cybernetics) for each cell count integrated optical density of green
channel.
C) Reverses
UV-induced Translational Inhibition--
To confirm that PERK mediates
UV-induced translational inhibition, protein synthesis after UV
irradiation in MCF-7 and the MCF-7-PERK
C cell line was measured.
Whereas protein synthesis was reduced to 18% in control MCF-7 cells at
24 h after 30 J/m2 UVC, protein synthesis remained at
50% in MCF-7-PERK
C cells (Fig.
5B). The incomplete protection
of UV-induced translational inhibition may be caused by the activation
of endogenous PERK or other factors (such as a ribotoxic stress
response) (16). Interestingly, when MCF-7-PERK
C cells were
irradiated with a high dose (100 J/m2) of UVC, PERK
C
failed to prevent UV-induced translational inhibition. Because
expression of PERK
C in the MCF-7-PERK
C is not reduced after UV
irradiation (Fig. 5C) the result suggests that another signaling pathway also may be involved in translational regulation after UV irradiation. Our data show that UV-induced translational inhibition is at least partially mediated through PERK (Fig. 5, A and B).

View larger version (31K):
[in a new window]
Fig. 5.
PERK mediates UV-induced translational
inhibition. 35S incorporation into proteins was
determined by trichloroacetic acid precipitation and expressed as a
percentage of 35S incorporation at the zero time point.
Error represents 1 S.D. calculated from 2-4 sets of independent
experiments. A, dose-dependent 35S
incorporation at 4 h postirradiation. B,
time-dependent 35S incorporation 30 J/m2 UV irradiation. C, PERK
C expression in
control and UV-irradiated cells.
C Dimerizes with Intact PERK (K618A)--
To examine the
possibility that overexpressed PERK mutants form inactive dimers with
endogenous PERK, a co-immunoprecipitation assay was established to
measure dimerization between intact PERK and the N-terminal luminal
domain of PERK in vivo. Because the wild-type PERK inhibits
translation of its own mRNA and is expressed at a very low level,
we used the kinase-inactive PERK mutant K618A in this analysis. COS-1
cells were transiently co-transfected with pETFVA
-PERK
(K618A)-myc and pETFVA
-PERK
C-T7. After
pulse-labeling the transfected cells with [35S]Met/Cys
the interaction between intact PERK and PERK
C was measured by
co-immunoprecipitation with monoclonal anti-T7 antibody (Novagen Corp.,
Madison, WI) or anti-myc antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Total cell protein extracts and the
immunoprecipitates were analyzed by SDS-PAGE. Immunoprecipitation of
the T7-tagged PERK
C yielded the expected polypeptide at 80 kDa as
well as a 130-kDa polypeptide that represented the PERK (K618A) (Fig.
6, lane 6).
Immunoprecipitation of the myc-tagged PERK (K618A) showed that expression levels of PERK (K618A) were slightly different in the
transfected cells (67:100; Fig. 6, lane 8 versus lane
9). PERK
C co-immunoprecipitated myc-tagged PERK
(K618A) (Fig. 6, lane 9). The amount of dimerization was
quantitated using NIH Image (Version 1.62f). The intensity of PERK
(K618A) was 24% of the associated PERK
C (Fig. 6, lane
6). The intensity of the PERK
C was 8.8% of the associated PERK
(K618A). After correcting the numbers for the molecular weight of the
peptides, the amount of heterodimerized peptides was 14.5 ± 0.2%. These results suggest that the overexpression of a mutated
PERK may inhibit endogenous PERK by forming inactive heterodimers.

View larger version (36K):
[in a new window]
Fig. 6.
PERK
C dimerizes with
intact PERK (K618A). Cell extracts were prepared from transiently
transfected and 35S-pulse-labeled COS-1 cells. Expressed
proteins were co-immunoprecipitated using anti-T7 or
anti-myc antibody as indicated. The cell extract and
immunoprecipitates were resolved by SDS-PAGE and analyzed by
autoradiography.
subsequently
results in protein synthesis inhibition. We also propose that upon PERK
activation the translation of selective mRNAs (such as
ATF4) (26, 27) increases. IRE1 is a protein kinase and
site-specific endoribonuclease that signals transcriptional activation
of a large set of genes upon activation of the unfolded protein
response in the ER (28). Because PERK and the protein kinase/endoribonuclease IRE1 both are activated by identical degrees and types of ER-stress (29, 30), upon UV irradiation IRE1 may also be
activated to signal the transcriptional activation of its target genes
that include CHOP10, BiP, and GADD34 (21, 26,
31). It has been suggested that IRE1 can cleave ribosomal RNA (32) and
that this may contribute to the ribotoxic effects associated with UV
irradiation (16). Increased expression of the eIF2
phosphatase
GADD34 may provide cell protection by reversing the translational
inhibition associated with PERK activation and eIF2
phosphorylation
(31), which is consistent with the reversal of eIF2
phosphorylation
and increased translation that we observed after longer periods of UV
treatment. In addition, activated IRE1 can activate JNK to initiate an
apoptotic program (33), a signaling pathway known to be activated by UV
light (34, 35). Future studies should elucidate the factors that
are required for PERK and/or IRE1 activation, and the studies also
should clarify the mechanisms for downstream signaling in response to
UV light. These studies should encourage the development of drugs to
target PERK and/or IRE1 in order to prevent and treat UV-related
development of skin cancers.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
![]()
ABBREVIATIONS
C, kinase domain deleted PERK (residues 1-536);
eIF2
,
-subunit of
eukaryotic initiation factor 2;
GFP, green fluorescent protein;
EGFP, enhanced GFP;
JNK, c-Jun NH2-terminal kinase;
OA, okadaic
acid;
HIT, hamster insulinoma tumor.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSIONS
REFERENCES
1.
Smith, M. L.,
and Fornace, A. J., Jr.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12255-12257 2.
Bissonnette, N.,
and Hunting, D. J.
(1998)
Oncogene
16,
3461-3469[CrossRef][Medline]
[Order article via Infotrieve] 3.
Wu, L.,
and Levine, A. J.
(1997)
Mol. Med.
3,
441-451[Medline]
[Order article via Infotrieve] 4.
Rehemtulla, A.,
Hamilton, C. A.,
Chinnaiyan, A. M.,
and Dixit, V. M.
(1997)
J. Biol. Chem.
272,
25783-25786 5.
Bender, K.,
Blattner, C.,
Knebel, A.,
Iordanov, M.,
Herrlich, P.,
and Rahmsdorf, H. J.
(1997)
J. Photochem. Photobiol. B Biol.
37,
1-17[CrossRef][Medline]
[Order article via Infotrieve] 6.
Fritz, G.,
and Kaina, B.
(1999)
Mol. Cell. Biol.
19,
1768-1774 7.
Shi, Y.,
Vattem, K. M.,
Sood, R., An, J.,
Liang, J.,
Stramm, L.,
and Wek, R. C.
(1998)
Mol. Cell. Biol.
18,
7499-7509 8.
Harding, H. P.,
Zhang, Y.,
and Ron, D.
(1999)
Nature
397,
271-274[CrossRef][Medline]
[Order article via Infotrieve] 9.
Silverman, R. H.,
and Williams, B. R.
(1999)
Nature
397,
208-211[CrossRef][Medline]
[Order article via Infotrieve] 10.
Kaufman, R. J.
(1999)
Genes Dev.
13,
1211-1233 11.
Hinnebusch, A. G.
(1994)
Trends Biochem. Sci.
19,
409-414[CrossRef][Medline]
[Order article via Infotrieve] 12.
Fernandez, J. M.,
Bode, B.,
Koromilas, A.,
Krukovets, I.,
Snider, M. D.,
and Hatzoglou, M.
(2002)
J. Biol. Chem.
277,
11780-11787 13.
Fernandez, J.,
Yaman, I.,
Merrick, W. C.,
Koromilas, A.,
Wek, R. C.,
Sood, R.,
Hensold, J.,
and Hatzoglou, M.
(2002)
J. Biol. Chem.
277,
2050-2058 14.
Fernandez, J.,
Yaman, I.,
Mishra, R.,
Merrick, W. C.,
Snider, M. D.,
Lamers, W. H.,
and Hatzoglou, M.
(2001)
J. Biol. Chem.
276,
12285-12291 15.
Zinszner, H.,
Kuroda, M.,
Wang, X.,
Batchvarova, N.,
Lightfoot, R. T.,
Remotti, H.,
Stevens, J. L.,
and Ron, D.
(1998)
Genes Dev.
12,
982-995 16.
Iordanov, M. S.,
Pribnow, D.,
Magun, J. L.,
Dinh, T. H.,
Pearson, J. A.,
and Magun, B. E.
(1998)
J. Biol. Chem.
273,
15794-15803 17.
DeGracia, D. J.,
Sullivan, J. M.,
Neumar, R. W.,
Alousi, S. S.,
Hikade, K. R.,
Pittman, J. E.,
White, B. C.,
Rafols, J. A.,
and Krause, G. S.
(1997)
J. Cereb. Blood Flow Metab.
17,
1291-1302[CrossRef][Medline]
[Order article via Infotrieve] 18.
Wu, S.,
and Kaufman, R. J.
(1997)
J. Biol. Chem.
272,
1291-1296 19.
Wu, S.,
and Kaufman, R. J.
(1996)
J. Biol. Chem.
271,
1756-1763 20.
Redpath, N. T.,
and Proud, C. G.
(1990)
Biochem. J.
272,
175-180[Medline]
[Order article via Infotrieve] 21.
Bertolotti, A.,
Zhang, Y.,
Hendershot, L. M.,
Harding, H. P.,
and Ron, D.
(2000)
Nat. Cell. Bio.
2,
326-332[CrossRef][Medline]
[Order article via Infotrieve] 22.
Merrick, W. C.
(1992)
Microbiol. Rev.
56,
291-315 23.
Der, S. D.,
Yang, Y. L.,
Weissmann, C.,
and Williams, B. R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3279-3283 24.
Luethy, J. D.,
Fargnoli, J.,
Park, J. S.,
Fornace, A. J., Jr.,
and Holbrook, N. J.
(1990)
J. Biol. Chem.
265,
16521-16526 25.
Wang, X. Z.,
Harding, H. P.,
Zhang, Y.,
Jolicoeur, E. M.,
Kuroda, M.,
and Ron, D.
(1998)
EMBO J.
17,
5708-5717[CrossRef][Medline]
[Order article via Infotrieve] 26.
Harding, H. P.,
Novoa, I. I.,
Zhang, Y.,
Zeng, H.,
Wek, R.,
Schapira, M.,
and Ron, D.
(2000)
Mol. Cell
6,
1099-1108[CrossRef][Medline]
[Order article via Infotrieve] 27.
Scheuner, D.,
Song, B.,
McEwen, E.,
Liu, C.,
Laybutt, R.,
Gillespie, P.,
Saunders, T.,
Bonner-Weir, S.,
and Kaufman, R. J.
(2001)
Mol. Cell
7,
1165-1176[CrossRef][Medline]
[Order article via Infotrieve] 28.
Tirasophon, W.,
Lee, K.,
Callaghan, B.,
Welihinda, A.,
and Kaufman, R. J.
(2000)
Genes Dev.
14,
2725-2736 29.
Bertolotti, A.,
and Ron, D.
(2001)
J. Cell Sci.
114,
3207-3212 30.
Liu, C. Y.,
Schroder, M.,
and Kaufman, R. J.
(2000)
J. Biol. Chem.
275,
24881-24885 31.
Novoa, I.,
Zeng, H.,
Harding, H. P.,
and Ron, D.
(2001)
J. Cell Biol.
153,
1011-1022 32.
Iwawaki, T.,
Hosoda, A.,
Okuda, T.,
Kamigori, Y.,
Nomura-Furuwatari, C.,
Kimata, Y.,
Tsuru, A.,
and Kohno, K.
(2001)
Nat. Cell Bio.
3,
158-164[CrossRef][Medline]
[Order article via Infotrieve] 33.
Urano, F.,
Wang, X.,
Bertolotti, A.,
Zhang, Y.,
Chung, P.,
Harding, H. P.,
and Ron, D.
(2000)
Science
287,
664-666 34.
Huang, C., Ma, W.,
Ding, M.,
Bowden, G. T.,
and Dong, Z.
(1997)
J. Biol. Chem.
272,
27753-27757 35.
Chatterjee, M.,
and Wu, S.
(2001)
Mol. Cell. Biochem.
219,
21-27[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. B. Salmon, A. A. S. Akha, R. Buffenstein, and R. A. Miller Fibroblasts From Naked Mole-Rats Are Resistant to Multiple Forms of Cell Injury, But Sensitive to Peroxide, Ultraviolet Light, and Endoplasmic Reticulum Stress J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2008; 63(3): 232 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baltzis, O. Pluquet, A. I. Papadakis, S. Kazemi, L.-K. Qu, and A. E. Koromilas The eIF2{alpha} Kinases PERK and PKR Activate Glycogen Synthase Kinase 3 to Promote the Proteasomal Degradation of p53 J. Biol. Chem., October 26, 2007; 282(43): 31675 - 31687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rahmani, E. M. Davis, T. R. Crabtree, J. R. Habibi, T. K. Nguyen, P. Dent, and S. Grant The Kinase Inhibitor Sorafenib Induces Cell Death through a Process Involving Induction of Endoplasmic Reticulum Stress Mol. Cell. Biol., August 1, 2007; 27(15): 5499 - 5513. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Zykova, F. Zhu, Y. Zhang, A. M. Bode, and Z. Dong Involvement of ERKs, RSK2 and PKR in UVA-induced signal transduction toward phosphorylation of eIF2{alpha} (Ser51) Carcinogenesis, July 1, 2007; 28(7): 1543 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tvegard, H. Soltani, H. C. Skjolberg, M. Krohn, E. A. Nilssen, S. E. Kearsey, B. Grallert, and E. Boye A novel checkpoint mechanism regulating the G1/S transition Genes & Dev., March 15, 2007; 21(6): 649 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Ungureanu, M. Cloutier, S. M. Lewis, N. de Silva, J. D. Blais, J. C. Bell, and M. Holcik Internal Ribosome Entry Site-mediated Translation of Apaf-1, but Not XIAP, Is Regulated during UV-induced Cell Death J. Biol. Chem., June 2, 2006; 281(22): 15155 - 15163. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mazan-Mamczarz, A. Lal, J. L. Martindale, T. Kawai, and M. Gorospe Translational Repression by RNA-Binding Protein TIAR. Mol. Cell. Biol., April 1, 2006; 26(7): 2716 - 2727. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Cybulsky, T. Takano, J. Papillon, and K. Bijian Role of the Endoplasmic Reticulum Unfolded Protein Response in Glomerular Epithelial Cell Injury J. Biol. Chem., July 1, 2005; 280(26): 24396 - 24403. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gorrini, F. Loreni, V. Gandin, L. A. Sala, N. Sonenberg, P. C. Marchisio, and S. Biffo Fibronectin controls cap-dependent translation through {beta}1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways PNAS, June 28, 2005; 102(26): 9200 - 9205. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thomas, Z. Yu, N. Dadgar, S. Varambally, J. Yu, A. M. Chinnaiyan, and A. P. Lieberman The Unfolded Protein Response Modulates Toxicity of the Expanded Glutamine Androgen Receptor J. Biol. Chem., June 3, 2005; 280(22): 21264 - 21271. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Casati and V. Walbot Crosslinking of Ribosomal Proteins to RNA in Maize Ribosomes by UV-B and Its Effects on Translation Plant Physiology, October 1, 2004; 136(2): 3319 - 3332. [Abstract] [Full Text] [PDF] |
||||
![]() |
|